Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NicoWater washes westward

This article was originally published in The Tan Sheet

Executive Summary

"Homeopathic nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings" will be sold throughout entire Rite Aid chain, Westlake Village, Calif.-based QT 5 announces Nov. 3. Chain is "first major retailer to bring our product to the entire West Coast market as well as many mid-western markets not previously served," firm says. NicoWater has been in distribution in northeast at Eckerd, Rite Aid and other stores since May. Product is marketed as homeopathic drug since objections from FDA quashed launch as dietary supplement (1"The Tan Sheet" March 17, 2003, In Brief). Nicorette gum marketer GlaxoSmithKline filed a citizen petition in March asserting water's potency falls outside legal potency for OTC homeopathics (2"The Tan Sheet" April 7, 2003, p. 7)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel